What America Lost by Delaying the Vaccine Rollout
In September 2020, regulators asked for extra safety data on the new mRNA vaccines. The human cost of that request is far from clear.

In September 2020, regulators asked for extra safety data on the new mRNA vaccines. The human cost of that request is far from clear.
A decision to go with a lower dose might have helped speed things up last year. Now we may be seeing the consequences.
The rare Chilean soapbark tree produces compounds that can boost the body’s reaction to vaccines.
In the beach towns south of Melbourne, everyone, it seems, knows someone who’s been attacked.
The vaccine for Hendra, a virus that can spread from horses to humans, has pitted owners against vets—revealing that science alone can't prevent the next global pandemic.
The transition out of high school can be especially difficult at schools that lack extra social resources.